STOK
Stoke Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +0.2% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 80 | -1 | 41.15M | $1.35B | +7 | −7 |
| Q1 2026 | 83 | +2 | 38.21M | $1.24B | +9 | −7 |
| Q4 2025 | 80 | -1 | 35.34M | $1.12B | +1 | −2 |
| Q3 2025 | 16 | +1 | 26.41M | $620.57M | +1 | — |
| Q2 2025 | 12 | 0 | 21.43M | $243.28M | +1 | −1 |
| Q1 2025 | 9 | -3 | 5.10M | $33.93M | — | −3 |
| Q4 2024 | 12 | +1 | 4.31M | $47.51M | +2 | −1 |
| Q3 2024 | 10 | +2 | 3.11M | $38.25M | +3 | −1 |
| Q2 2024 | 8 | — | 2.69M | $36.29M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 7.41M | — | $84.14M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 7.41M | — | $84.14M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 7.41M | — | $84.14M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 5.92M | — | $67.24M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 5.92M | — | $67.24M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 5.92M | — | $67.24M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 5.92M | — | $67.24M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 5.92M | — | $67.24M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 5.92M | — | $67.24M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 5.92M | — | $67.24M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 5.92M | — | $67.24M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 5.92M | — | $67.24M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 5.92M | — | $67.24M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 5.92M | — | $67.24M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 5.92M | — | $67.24M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 5.92M | — | $67.24M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 5.92M | — | $67.24M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passief) | 2.95M | — | $33.44M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passief) | 2.95M | — | $33.44M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passief) | 2.95M | — | $33.44M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passief) | 2.95M | — | $33.44M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (passief) | 2.95M | — | $33.44M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Marshall Wace ✦ | 2.30M | +7.9% | $26.11M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Marshall Wace ✦ | 2.30M | +7.9% | $26.11M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | State Street Global Advisors ✦ (passief) | 1.49M | -5.6% | $16.88M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 26 | Geode Capital Management ✦ (passief) | 972.92K | +7.9% | $11.04M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Geode Capital Management ✦ (passief) | 972.92K | +7.9% | $11.04M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Wellington Management ✦ | 137.07K | +0.8% | $1.56M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Wellington Management ✦ | 137.07K | +0.8% | $1.56M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Wellington Management ✦ | 137.07K | +0.8% | $1.56M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 103.24K | -4.0% | $1.17M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 103.24K | -4.0% | $1.17M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 54.82K | +326.7% | $622,184 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 54.82K | +326.7% | $622,184 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 54.82K | +326.7% | $622,184 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 54.82K | +326.7% | $622,184 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 54.82K | +326.7% | $622,184 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 38 | T. Rowe Price ✦ | 43.73K | +11.9% | $497,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | D. E. Shaw & Co. ✦ | 30.70K | Nieuw | $348,400 | 0.0% | New | 1 | SEC ↗ |
| 40 | D. E. Shaw & Co. ✦ | 30.70K | Nieuw | $348,400 | 0.0% | New | 1 | SEC ↗ |
| 41 | Millennium Management ✦ | 20.40K | +4.0% | $231,495 | 0.0% | ▲ Add | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| D. E. Shaw & Co. | $348,400 | 0.0% |
| D. E. Shaw & Co. | $348,400 | 0.0% |
Verlaten
| Renaissance Technologies | $1.19M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 196 houders, 69.25M aandelen, $2.18B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 2.72K aand · $86,932
Officer · 145 aand · $4,708
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie